Treatments
Stem cells to treat Parkinson’s? Two small studies hint at success
Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.
Pig kidney transplant fails after patient rejection
Surgeons at NYU Langone Health in New York City had to remove a genetically modified pig kidney from Towana Looney, 53, of Gadsden, Ala., because her body rejected the organ. She's back on dialysis.
Pain pathway in a dish could aid search for new analgesic drugs
Scientists have recreated a pathway that senses pain, using clusters of human nerve cells grown in a dish.
The (artificial intelligence) therapist can see you now
Many AI products claim to deliver mental health therapy, but with little quality control. But new research suggests with the right training, AI can be effective at helping people.
Latest Alzheimer’s lab tests focus on memory loss, not brain plaques
New tests of blood and spinal fluid can identify people experiencing memory loss from Alzheimer's disease.
March Madness is a season for betting, but help for problem gambling is hard to find
For people with gambling disorder, the proliferation of gambling opportunities makes it difficult to fight their addiction. Investment in treatment lags behind other addiction disorders.
Doctors still seeking cure for brain cancer that struck former Utah Rep. Mia Love
Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a brain cancer that is nearly always fatal.
Patients scramble as cheaper obesity drug alternatives disappear
Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop Wednesday. That's left many patients wondering what to do next.
5 years since the pandemic started, long COVID patients are still hoping for a cure
They're pushing for more funding to find effective treatments. Researchers are finally starting to make headway but have a way to go.
Nominee to run NIH faces Senate scrutiny
Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Alzheimer’s was taking her memory, so she started taking a new drug
Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.
Did an Alzheimer’s drug give Sue and Ken Bell more time? Maybe
Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband isn't sure if it made a difference.
When online weight-loss drugs are too good to be true
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy of the weight-loss medicines it mailed to patients.
His genes forecast Alzheimer’s. His brain had other plans.
Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy at 75.
